These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 10414592)

  • 21. Hairy cell leukemia: clinical, pathological and ultrastructural findings in Asian-Indians.
    Chatterjee T; Panigrahi I; Mahapatra M; Pati HP; Kumar R; Naithani R; Wadhwa S; Choudhry VP; Saxena R
    Indian J Cancer; 2008; 45(2):41-4. PubMed ID: 18626146
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The diagnosis of hairy cell leukemia can be established by flow cytometric analysis of peripheral blood, even in patients with low levels of circulating malignant cells.
    Cornfield DB; Mitchell Nelson DM; Rimsza LM; Moller-Patti D; Braylan RC
    Am J Hematol; 2001 Aug; 67(4):223-6. PubMed ID: 11443633
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 2-chlorodeoxyadenosine (cladribine) in the treatment of hairy cell leukemia and hairy cell leukemia variant: 7-year experience in Poland.
    Robak T; Błasińska-Morawiec M; Błoński J; Hellmann A; Hałaburda K; Konopka L; Kotlarek-Haus S; Potoczek S; Hansz J; Dmoszyńska A; Urasiński I; Zdziarska B; Dwilewicz-Trojaczek J; Hołowiecki J; Skotnicki AB
    Eur J Haematol; 1999 Jan; 62(1):49-56. PubMed ID: 9918312
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic application of two-color flow cytometry in 161 cases of hairy cell leukemia.
    Robbins BA; Ellison DJ; Spinosa JC; Carey CA; Lukes RJ; Poppema S; Saven A; Piro LD
    Blood; 1993 Aug; 82(4):1277-87. PubMed ID: 7688993
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Flow Cytometry of CD5-Positive Hairy Cell Leukemia.
    Cenariu D; Rus I; Bergthorsson JT; Grewal R; Cenariu M; Greiff V; Tigu AB; Dima D; Selicean C; Petrushev B; Zdrenghea M; Fromm J; Aanei CM; Tomuleasa C
    Mol Diagn Ther; 2023 Sep; 27(5):593-599. PubMed ID: 37291380
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Basic fibroblast growth factor is expressed by CD19/CD11c-positive cells in hairy cell leukemia.
    Gruber G; Schwarzmeier JD; Shehata M; Hilgarth M; Berger R
    Blood; 1999 Aug; 94(3):1077-85. PubMed ID: 10419901
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of hairy cell leukemia in a patient treated with cytoreductive agents for essential thrombocythemia.
    Azagury M; Martelli JM; Morcelet M; Duboucher C; Flandrin G
    Leuk Lymphoma; 2003 Jun; 44(6):1067-9. PubMed ID: 12854912
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Simultaneous manifestation of chronic lymphocytic leukemia (CLL) and hairy cell leukemia (HCL).
    Sokol L; Agosti SJ
    Am J Hematol; 2004 Feb; 75(2):107-9. PubMed ID: 14755378
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Hairy cell leukemia--a potentially curable malignancy. Selected aspects of purine analog therapy].
    Rucińska M; Machaczka M; Załuska A; Skotnicki AB
    Przegl Lek; 1998; 55(7-8):400-6. PubMed ID: 10021885
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 2-chlorodeoxyadenosine (cladribine) in the treatment of hairy cell leukemia.
    Yang MH; Ho CH
    Zhonghua Yi Xue Za Zhi (Taipei); 2001 Jan; 64(1):54-8. PubMed ID: 11310372
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Hairy cell leukemia therapy by cladribine].
    Ogura M
    Nihon Rinsho; 2004 Jul; 62(7):1337-42. PubMed ID: 15283153
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Successful induction and complete improvement of myelofibrosis and erythema nosodum with cladribine in a case of hairy cell leukemia].
    Araki H; Matsunaga T; Murase K; Kuroda H; Kuribayashi K; Terui T; Niitsu Y
    Gan To Kagaku Ryoho; 2004 Jun; 31(6):965-9. PubMed ID: 15222122
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunophenotype of hairy-cell leukemia.
    Hassan IB; Hagberg H; Sundström C
    Eur J Haematol; 1990 Sep; 45(3):172-6. PubMed ID: 2226730
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pulmonary damage in a patient with hairy cell leukemia - infectious involvement or hematological disease activity? Case report.
    Ecsiova D; Kamaradova K; Nova M; Hoffmann P; Rozsivalova P; Simkovic M; Zak P
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2023 Dec; 167(4):385-389. PubMed ID: 35713332
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hairy cell leukemia-variant--a case report.
    Gupta K; Jasmina A; Malhotra P; Varma N; Vaiphei K; Vohra H; Varma S; Garewal G
    Indian J Pathol Microbiol; 2005 Jul; 48(3):387-9. PubMed ID: 16761764
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Successful induction of long-term remission using rituximab in a patient with refractory hairy cell leukemia-Japanese variant.
    Imamura T; Ohtsuka E; Ogata M; Oka F; Kashima K; Kikuchi H; Nasu M
    Int J Hematol; 2004 Dec; 80(5):432-4. PubMed ID: 15646655
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rituximab in the treatment of the variant of hairy cell leukaemia: a case report.
    Hadzi-Pecova L; Stojanovik A; Petrusevska G; Panovska I
    Prilozi; 2008 Dec; 29(2):355-60. PubMed ID: 19259059
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cladribine in hairy cell leukemia.
    Belani R; Saven A
    Hematol Oncol Clin North Am; 2006 Oct; 20(5):1109-23. PubMed ID: 16990111
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hairy cell leukemia and sarcoidosis: a case report and review of the literature.
    Schiller G; Said J; Pal S
    Leukemia; 2003 Oct; 17(10):2057-9. PubMed ID: 14513061
    [No Abstract]   [Full Text] [Related]  

  • 40. Hairy cell leukaemia-variant: Disease features and treatment.
    Matutes E; Martínez-Trillos A; Campo E
    Best Pract Res Clin Haematol; 2015 Dec; 28(4):253-63. PubMed ID: 26614904
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.